Stay updated on Avapritinib in Advanced Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib in Advanced Mastocytosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new publication citation for PATHFINDER 4-year follow-up in Blood Advances was added to the Publications section, noting long-term results of avapritinib in advanced systemic mastocytosis.SummaryDifference0.0%

- Check20 days agoChange DetectedA new revision tag 'Revision: v3.5.4' appears, replacing the prior 'Revision: v3.5.3', indicating a minor metadata update to the page.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s results section has been updated to reflect newly posted trial outcomes, including primary efficacy (ORR) and related response measures based on the mIWG-MRT-ECNM criteria. It also updates the defined secondary endpoint measurements for symptoms, quality of life, and treatment-emergent adverse events, along with associated timeframes and assessment methods.SummaryDifference4%

- Check48 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. No visible changes to the study details are shown.SummaryDifference0.0%

Stay in the know with updates to Avapritinib in Advanced Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.